IGIlya N. Ganebnykh

Ilya N. Ganebnykh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ilya N. Ganebnykh has a total of 85 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    1-Azinyl-1′-Alkenylferrocenes with Anticholinesterase, Antioxidant, and Antiaggregating Activities as Multifunctional Agents for Potential Treatment of Alzheimer’s Disease

    by Galina F. Makhaeva, Irina A. Utepova, Elena V. Rudakova, Nadezhda V. Kovaleva, Natalia P. Boltneva, Elena Yu. Zyryanova, Alexandra A. Musikhina, Vladimir F. Lazarev, Snezhana A. Vladimirova, Irina V. Guzhova, et al.

    Background/Objectives: This study focused on synthesizing novel alkenyl derivatives of azinylferrocenes and evaluating their potential as Alzheimer’s disease (AD) therapeutics. Methods: 1-Azinyl-1′-acetylferrocenes were obtained by regioselective acetylation of azinylferrocenes, followed by the Wittig reaction or reduction of 1-azinyl-1′-acetylferrocenes and subsequent dehydration of the resulting alcohols. The synthesized compounds underwent the following biological activity testing relevant to AD: inhibition of acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and off-target carboxylesterase (CES); antioxidant capacity (ABTS and FRAP assays); inhibition of Aβ42 self-aggregation (thioflavin method); blocking AChE-induced β-amyloid aggregation (propidium displacement); and cytotoxicity in SH-SY5Y and MSC-Neu cells (MTT assay). Results: Quinoline and bipyridine derivatives demonstrated effective cholinesterase inhibition, especially quinoline 7b (AChE IC50 3.32 μM; BChE IC50 3.68 μM), while acridine derivatives were poor inhibitors. Quantum chemical (QC) calculations predicted that acridine derivatives were especially prone to form stable dimers. Molecular docking into protein targets generated by an AlphaFold3 reproduction code showed that these dimers were too bulky to access enzyme active sites, yet they could bind to protein surfaces to inhibit Aβ42 self-aggregation and displace propidium from the AChE peripheral anionic site. All compounds showed high antioxidant activity in ABTS and FRAP assays, with quinoline derivatives being 2–4 times more potent than Trolox. QC calculations supported these findings. Quinoline and bipyridine derivatives also exhibited low cytotoxicity and scant CES inhibition. Conclusions: Overall, the synthesized ferrocenes, particularly the quinoline and bipyridine derivatives, appear promising for further research as multifunctional therapeutic agents targeting AD due to their anticholinesterase, antiaggregating, and antioxidant activities combined with low toxicity.


  • Open Access

    1-Azinyl-1’-Alkenylferrocenes with Anticholinesterase, Antioxidant, and Antiaggregating Activities as Multifunctional Agents for Potential Treatment of Alzheimer’s Disease

    by Galina F. Makhaeva, Irina A. Utepova, Elena V. Rudakova, Nadezhda V. Kovaleva, Natalia P. Boltneva, Elena Yu. Zyryanova, Alexandra A. Musikhina, Vladimir F. Lazarev, Snezhana A. Vladimirova, Irina V. Guzhova, et al.

    Background/Objectives: This study focused on synthesizing novel alkenyl derivatives of azinylferrocenes and evaluating their potential as Alzheimer’s disease (AD) therapeutics. Methods: 1-Azinyl-1’-acetylferrocenes were obtained by regioselective acetylation of azinylferrocenes, followed by the Wittig reaction or reduction of 1-azinyl-1’-acetylferrocenes and subsequent dehydration of the resulting alcohols. The synthesized compounds underwent the following biological activity testing relevant to AD: inhibition of acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and off-target carboxylesterase (CES); antioxidant capacity (ABTS and FRAP assays); inhibition of A42 self-aggregation (thioflavin method); blocking AChE-induced β-amyloid aggregation (propidium displacement); and cytotoxicity in SH-SY5Y and MSC-Neu cells (MTT assay). Results: Quinoline and bipyridine derivatives demonstrated effective cholinesterase inhibition, especially quinoline 7b (AChE IC₅₀ 3.32 μM; BChE IC₅₀ 3.68 μM), while acridine derivatives were poor inhibitors. Quantum chemical (QC) calculations predicted that acridine derivatives were especially prone to form stable dimers. Molecular docking into protein targets generated by an AlphaFold3 reproduction code showed that these dimers were too bulky to access enzyme active sites, yet they could bind to protein surfaces to inhibit A42 self-aggregation and displace propidium from the AChE peripheral site. All compounds showed high antioxidant activity in ABTS and FRAP assays, with quinoline derivatives being 2–4 times more potent than Trolox. QC calculations supported these findings. Quinoline and bipyridine derivatives also exhibited low cytotoxicity and scant CES inhibition. Conclusions: Overall, the synthesized ferrocenes, particularly the quinoline and bipyridine derivatives, appear promising for further research as multifunctional therapeutic agents targeting AD due to their anticholinesterase, antiaggregating, and antioxidant activities combined with low toxicity.

  • Open Access

    Nido-Carborane Derivatives of (S)-Ornithine and (S)-Lysine as Potential Boron Delivery Agents: Synthesis and In Vitro Evaluation

    by Dmitry A. Gruzdev, Galina L. Levit, Vera V. Musiyak, Angelina A. Telegina, Ilya N. Ganebnykh, Marina A. Ezhikova, Mikhail I. Kodess, Olga I. Solovieva, Tatiana Y. Gusel’nikova, Ivan A. Razumov, et al.

    Derivatives of natural amino acids are selectively absorbed by many types of tumour cells. This makes the use of amino acids, especially polyfunctional ones, attractive as a basis in the design of low-toxicity agents for targeted boron delivery for boron neutron capture therapy (BNCT) of tumours. We synthesized a series of new (S)-ornithine and (S)-lysine derivatives containing a 7,8-dicarba-nido-undecaborane (nido-carborane) residue attached to the amino group in the side chain or alpha position. The MTT assay demonstrated moderate cytotoxicity of the lysine and ornithine derivatives containing a nido-carborane residue in the side chain. It has been found that sodium salt of Nε-(nido-carboran-7-yl)acetyl-(S)-lysine is capable of accumulation by MDA-MB-231 (human breast carcinoma) and SK-Mel 28 (human melanoma) cell lines, providing a boron concentration of up to 0.67 µg/106 cells in in vitro experiments. This (S)-lysine derivative containing a nido-carborane residue in the side chain can be considered as a promising compound for in-depth study in vivo experiments aimed at designing an efficient boron delivery agent for BNCT.


  • Synthesis of Trifluoromethyl-Substituted Imidazolidine-2-thiones and Their Reactions with Urea, 2-Aminoethanol, and 2-Aminophenol

    by L. V. Saloutina, M. I. Kodess, I. N. Ganebnykh, V. I. Saloutin, O. N. Chupakhin

    Perfluorobiacetyl reacted with thiourea, N-methylthiourea, and N-phenylthiourea in acetonitrile to give 92–95% of cis/trans-isomeric 4,5-dihydroxy-4,5-bis(trifluoromethyl)imidazolidine-2-thione and 1-methyl­(phenyl)-4,5-dihydroxy-4,5-bis(trifluoromethyl)imidazolidine-2-thiones. The reaction of 4,5-dihy­droxy-4,5-bis(trifluoromethyl)imidazolidine-2-thione with 2-aminoethanol produced sulfanylideneimidazothiazolone, whereas the expected imidazooxazinethione was formed as a minor product. An unusual pathway was observed in the reaction of N-methylimidazolidine-2-thione with 2-aminoethanol, which afforded thiohydantoins, 5-[(2-hydroxyethyl)amino]-3-methyl-2-sulfanylidene-5-(trifluoromethyl)imidazolidin-4-one and 5-hydroxy-3-methyl-2-sulfanylidene-5-(trifluoromethyl)imidazolidin-4-one. N-Methylsulfanylideneimidazooxazolone and N-methyl(trifluoromethyl)thiohydantoin were formed instead of the expected thioglycoluril derivative in the reaction of N-methylimidazolidine-2-thione with urea. Heating of 4,5-dihydroxy-1-phenyl-4,5-bis(tri­fluoro­methyl)imidazolidine-2-thione with urea, 2-aminoethanol, or 2-aminophenol in N,N-dimethylacetamide led to the formation of intramolecular rearrangement product, N-phenyl-bis(trifluoromethyl)thiohydantoin.

  • Three-Component Cyclization of Phenyl 1,3-Dicarbonyls with α,β-Enaldehydes and 2-(Aminomethyl)aniline to Pyrido[2,1-b]quinazolines

    by S. O. Kushch, M. V. Goryaeva, Ya. V. Burgart, M. A. Ezhikova, M. I. Kodess, P. A. Slepukhin, O. V. Koryakova, I. N. Ganebnykh, V. I. Saloutin

    The three-component condensation of phenyl-substituted 1,3-dicarbonyl compounds, α,β-un­saturated aldehydes, and 2-(aminomethyl)aniline under mild conditions resulted in regio- and chemoselective formation of tetrahydro-7H-pyrido[2,1-b]quinazoline derivatives as mixtures of trans and cis diastereomers, most of which were isolated as individual isomers. Their steric structure was determined by 1H and 13C NMR spectroscopy, including two-dimensional 1H–13C HSQC/HMBC and 1H–1H NOESY experiments, as well as by X-ray analysis.

  • Synthesis of Conjugates of N-(Purin-6-yl)-6-aminohexanoic Acid with 4-Amino-1-aryl-5-oxoprolines

    by A. Yu. Vigorov, O. A. Vozdvizhenskaya, A. A. Tumashov, T. V. Matveeva, I. N. Ganebnykh, G. L. Levit, V. P. Krasnov

    (2S,4S)-4-Amino-1-aryl-5-oxoprolines were synthesized by nucleophilic substitution of the bromine atom in dimethyl (2S,4RS)-4-bromo-N-phthaloylglutamate under the action of difluorosubstituted anilines followed by isolation of (2S,4S)-diastereomers and removal of protecting groups; subsequent coupling of their methyl esters with N-(purin-6-yl)-6-aminohexanoic acid and saponification of ester groups led to the formation of target conjugates. The saponification of ester groups was accompanied by minor epimerization.

  • Synthesis of Conjugates of N-(Purin-6-yl)-6-Aminohexanoic Acid with 4-Amino-1-Aryl-5-Oxoprolines

    by A. Yu. Vigorov, O. A. Vozdvizhenskaya, A. A. Tumashov, T. V. Matveeva, I. N. Ganebnykh, G. L. Levit, V. P. Krasnov

    (2S,4S)-4-Amino-1-aryl-5-oxoprolines were synthesized by nucleophilic substitution of the bromine atom in dimethyl (2S,4RS)-4-bromo-N-phthaloylglutamate under the action of difluorosubstituted anilines followed by isolation of (2S,4S)-diastereomers and removal of protecting groups; subsequent coupling of their methyl esters with N-(purin-6-yl)-6-aminohexanoic acid and saponification of ester groups led to the formation of target conjugates. The saponification of ester groups was accompanied by minor epimerization.

  • Open Access

    Hemostatic Antimicrobial Hydrogels Based on Silicon, Iron, Zinc, and Boron Glycerolates for Wound Healing Applications

    by Tat’yana Khonina, Semyon Alekseenko, Elena Shadrina, Il’ya Ganebnykh, Alexander Mekhaev, Leonid Larionov, Maria Dobrinskaya, Nadezhda Izmozherova, Irina Antropova, Maxim Karabanalov, et al.

    The use of glycerolates of biogenic elements as biocompatible precursors in sol–gel synthesis is an innovative direction and opens up new scientific and practical prospects in chemistry and technology of producing practically important biomedical materials, including hemostatic, antimicrobial, and wound healing materials. Using biocompatible precursors, silicon, zinc, boron, and iron glycerolates, new bioactive nanocomposite hydrogels were obtained by the sol–gel method. The composition and structural features of the hydrogels were studied using a complex of modern analytical techniques, including TEM, XRD, AES, and ESI MS. Hemostatic activity of the hydrogels was studied in the in vivo experiments; using the example of silicon-iron-zinc-boron glycerolates hydrogel, primary toxicological studies were carried out. Antimicrobial properties of hydrogels were studied using the agar diffusion method. The structural features of hydrogels and their relationship to medical and biological properties were revealed. It was shown that glycerolates hydrogels are non-toxic, and exhibit pronounced hemostatic activity, generally comparable to the commercial hemostatic drug Capramine. Antimicrobial activity is more pronounced for silicon-iron-zinc-boron and silicon-iron-boron glycerolates gel. The results obtained indicate that these glycerolates hydrogels are potential hemostatic and antibiotic-independent antimicrobial agents for topical wound healing applications in medical and veterinary practice.


  • Open Access

    Antituberculosis activity of some 3,6-disubstituted 1,2,4,5-tetrazines

    by Rashida I. Ishmetova, Ilya N. Ganebnykh, Nina K. Ignatenko, Irina G. Ovchinnikova, Olga V. Fedorova, Sergei N. Skornyakov, Gennady L. Rusinov

    The increase in the incidence of tuberculosis, especially in the post-Covid period, associated with the presence of latent infections and multiple drug resistance, dictates the need to develop new antimicrobial drugs. Here we wish to report the synthesis of 3,6-disubstituted 1,2,4,5-tetrazine derivatives containing N-, O- and C-nucleophile residues, as well as pharmacophoric hydrazone and oligooxyethylene fragments, and their screening against the pathogen Mycobacterium tuberculosis. Substances with pronounced antimycobacterial activity in vitro were identified (MIC = 0.18–3.12 μg/ml). An acute toxicity in vivo and membranotropic properties towards biometals have been studied for the most active compounds.